Abnova Corp. is a leading biotechnology company that specializes in the development and production of antibodies and related biological reagents on a commercial scale. Its primary purpose is to supply a diverse range of bio-products for high-throughput research and diagnostic purposes, catering to the needs of scientists and medical researchers globally. With a focus on genomics and proteomics, Abnova leverages cutting-edge technology to produce comprehensive antibody libraries, genetic tools, and diagnostic kits. These products serve critical roles in the pharmaceutical, life sciences, and healthcare sectors by facilitating advanced research and the development of new therapeutic solutions. Headquartered in Taiwan, Abnova Corp. maintains a strong presence in the global biotech market, contributing significantly to advancements in biomarker discovery and personalized medicine. Its extensive pipeline of innovative products underscores its commitment to precision and quality, rendering it a valuable partner for research institutions and biotech companies alike.